Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risks in the general population. Patients with rheumatoid arthritis (RA) carry an excess risk for CVD....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yao-Wei Zou, Qian-Hua Li, Jing-Wei Gao, Jie Pan, Jian-Da Ma, Le-Feng Chen, Jian-Zi Lin, Ying-Qian Mo, Xue-Pei Zhang, Pin-Ming Liu, Lie Dai
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2022-05-01
Collection:Frontiers in Cardiovascular Medicine
Sujets:
cardiovascular disease
rheumatoid arthritis
metabolic dysfunction-associated fatty liver disease
non-alcoholic fatty liver disease
inflammation
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires